. Author manuscript; available in PMC: 2022 Apr 1.

Published in final edited form as: Diabetologia. 2021 Jan 26;64(4):836–844. doi: 10.1007/s00125-020-05365-4

Table 1.

Comparisons between groups at baseline

	Glu(+) N = 76	lnd(+) N = 113	Glu(+)/Ind(+) N = 165
Age (years)	22.9±13.9	11.8±11.0^***	14.7±10.7^***
Overweight or obese: n (%)	44 (58)	18 (16)	50 (30)
Missing	0	2	1
≥2 Positive islet autoantibodies: n (%)	55 (72)	104 (92)^**	153 (93)^***

mlAA positive: n (%)	22 (29)	59 (52)^**	77 (47)^*

GADA positive: n (%)	64 (84)	95 (84)	140 (85)

IA-2A positive: n (%)	43 (57)	73 (65)	121 (73)^*

ICA positive: n (%)	44 (59)	83 (76)^*	112 (69)
Missing	2	4	2
ZnT8A positive: n (%)	30 (54)	54 (65)	70 (59)
Not tested/missing	20	30	46
HLA DR3-DQ2/DR4-DQ8: n (%)	13 (17)	31 (27)	41 (25)

Fasting C-peptide (nmol/l)	0.80±0.43	0.33±0.17^***	0.50±0.30^***

Early (30 – 0 min) C-peptide (nmol/l min)	1.00±0.57	0.50±0.23^***	0.43±0.30^***

Mean AUC C-peptide (nmol/l)	2.33±0.90	1.13±0.37^***	1.10±0.50^***

Values are mean (SD) unless otherwise noted

^***

p<0.0001

^**

p<0.01

p<0.05 in comparison to Glu(+)